C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors Eli Lilly & CO Transaction History
C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors
- $845 Billion
- Q1 2024
A detailed history of C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, C2 P Capital Advisory Group, LLC D.B.A. Prosperity Capital Advisors holds 1,640 shares of LLY stock, worth $1.35 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
1,640
Previous 1,193
37.47%
Holding current value
$1.35 Million
Previous $696 Million
83.51%
% of portfolio
0.15%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
3,767Shares Held
737MCall Options Held
7.09MPut Options Held
7.22M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$80 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$59.7 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$53.6 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$42.2 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$28.1 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $780B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...